Tetsuji Yamaguchi
Toyama, 9300194, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 19, 2017
Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
Journal: Advances in experimental medicine and biology
Published: June 01, 2017
Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Journal: International journal of oncology
Published: February 16, 2017
A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective Agonist.
Journal: Molecular cancer therapeutics
Published: August 19, 2016
p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
Journal: International journal of oncology
Published: December 08, 2015
Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer.
Journal: World journal of surgical oncology
Published: November 26, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026